Papers provide an opportunity to present original research findings related to any of the conference themes or other drug policy topics. The presentations slots are 15 minutes, and a written version of your paper (up to 4,000 words and formatted for journal submission) will be provided to delegates before the conference. The expectation is that delegates will have read the paper and hence the oral presentation focusses on key findings and then opportunity for discussion. All paper sessions will include a discussant.

In your submission for a paper, please use structured abstract headings (e.g. introduction, methods, results, discussion) for your 200-400 word abstract. If accepted, your abstract will appear as you have submitted it, in the book of abstracts.